JP Morgan Chase & Co.
JPM · NYSE
JPM · NYSE
JPMorgan Chase is a diversified financial-services company serving consumers, businesses, governments and institutional investors. Its activities span consumer and community banking, commercial banking, corporate and investment banking, and asset and wealth management. It earns from lending and deposit spreads, payments and account services, investment banking and trading, and fees for managing assets and wealth. The supplied evidence does not provide segment revenue shares, so the relative contributions of those businesses cannot be quantified here. JPMorgan reports FY2025 revenue of $182.4 billion and net income of $57.0 billion, compared with $177.6 billion and $58.5 billion, respectively, in FY2024.
JPM gained 2.09%, rising from $336.54 to $343.58. It first fell to $331.58 on October 23, then advanced in each reported session from October 26 through October 29. The supplied evidence does not establish a dated company announcement as the cause of that rebound. Zacks coverage pointed to JPMorgan’s raised 2026 net interest income outlook, citing loan and deposit growth, while also highlighting rising expenses, credit risks and a premium valuation; a separate article discussed approval for a merchant bank in Nigeria. Those items provide company-specific context, but the evidence does not link either to the week’s price action. No broad-market or peer-share performance is supplied for comparison.
JPM fell $0.77, or 0.23%, from $334.30 on October 12 to $333.53 on October 19. The week was volatile: shares dropped to $331.43 Tuesday, then recovered over the next three sessions to $339.72 Friday, before falling $6.19 on Monday and erasing that rebound. The supplied headlines mention JPMorgan’s security initiative reaching $230 billion and new-branch profitability, but provide no dated evidence tying either story to the week’s daily moves. On the evidence provided, the stock traded without a clear company-specific catalyst; no market benchmark is supplied to put its performance in broader context.
JPMorgan shares rose $1.92, or 0.58%, from $332.38 to $334.30 over the period. The move was not a steady advance: the stock fell for three sessions, reaching $329.58 on October 7, then recovered over the next three closes and finished above its starting level on October 12. The supplied evidence does not date any company-specific catalyst to those sessions, so the Q3 headlines and analyst commentary cannot be tied confidently to the price swings. Nor does the evidence provide a market or sector benchmark to explain the recovery. On the available data, shares reversed an early-week decline and ended modestly higher, without a clearly established news driver.
JPM fell 1.10% across the supplied trading window, from $334.98 to $331.28. It dropped to $330.83 on September 30, recovered to $333.18 the next day, then eased to $332.38 on October 2 and was unchanged on October 5 before slipping to $331.28 on October 6. TradingView attributed pressure on JPMorgan shares to higher yields testing trading momentum; the supplied evidence does not identify a company-specific announcement that explains the decline. Investors were also approaching the October 13 earnings report, with previews focused on expected earnings growth and whether strong banking momentum would continue, but the evidence does not establish that expectations drove the week's price moves.
JPM fell 1.59%, from $338.56 to $333.18, over the stated week. It dropped to $336.59 on Monday, then declined for two more sessions to $330.83 on Wednesday before recovering to $333.18 Thursday, leaving the rebound short of offsetting the earlier losses. The supplied evidence identifies no company-specific announcement that explains the weekly move. Zacks reported that JPM fell 1.89% on Monday, but its snippet gives no cause; the other market-related snippets do not establish a specific catalyst for JPM during this period. Trading therefore appears to have reflected market forces or positioning that the available evidence does not identify, rather than a documented company event.
JPMorgan Chase fell 3.26% over the stated period, from $348.92 to $337.53. It rose to $352.04 on Monday, September 21, then dropped sharply to $340.00 on Tuesday and slipped again to $337.53 on Wednesday, more than erasing Monday’s advance. The supplied evidence does not establish a dated company-specific event behind that reversal: Jefferies’ price-target cut has no date, and other company-related headlines do not link their news to the trading days. Nor does the evidence provide a market or banking-sector benchmark to explain the move in context. The week’s decline is therefore unexplained by the supplied catalysts, rather than attributable to a documented company announcement.
JPMorgan fell 2.37% over the week, from $358.64 to $350.13, with the decline concentrated in the final session, when volume rose to 9.6 million shares. The stock had already eased from $358.64 on September 4 to $353.51 on September 8, briefly recovered to $356.23 by September 11, and then reversed sharply lower on September 14. No company-specific announcement in the supplied evidence clearly explains the selloff. Trading instead occurred against a backdrop of rising-rate and market-volatility concerns, uncertainty around oil markets and Iran, and debate over whether JPMorgan’s strong capital-markets outlook can sustain fee growth. Dividend coverage and valuation commentary provided competing signals but did not prevent the weekly decline.
JPMorgan fell $2.51, or 0.71%, from $356.02 to $353.51 over the period. Trading was volatile: the stock slipped to $354.95 on September 1, recovered to $356.22 on September 2, then gained 1.6% to $362.06 on September 3 before giving back that advance and closing at $358.64 on September 4. It then fell another 1.4% to $353.51 on September 8. The supplied evidence does not identify a company-specific announcement explaining the reversal. Coverage was mixed, with Bank of America describing JPMorgan as an attractive risk/reward opportunity, while other articles highlighted reasons to sell and the stock’s sensitivity ahead of the Federal Reserve’s September decision.
JPMorgan rose $7.84, or 2.21%, from $354.22 to $362.06 over the reported week. The stock slipped from $356.02 on Monday to $354.95 on Tuesday before recovering to $356.22 on Wednesday, then jumped 1.64% on Thursday to finish at the weekly high. No company-specific announcement in the supplied evidence clearly explains the late-week surge. The move instead coincided with a broader financial-sector backdrop in which September oil, interest-rate and employment pressures were described as potentially favoring financial stocks over growth shares. Discussion of JPMorgan’s higher buybacks, dividend, branch expansion, bond issuance and Kinexys payments platform provided supportive themes, but the evidence does not establish any of them as the immediate catalyst.
JPMorgan rose 0.76% over the week, from $351.55 to $354.22. The stock made its largest move at the start, jumping from $351.58 on Friday to $356.39 on Monday, then adding modestly on Tuesday to $356.69. It held near that level Wednesday before giving back most of the early gain Thursday, closing at $354.22. No company-specific announcement is identified as the clear weekly catalyst. Trading instead occurred against broader concerns about elevated S&P 500 valuations, Wall Street leverage risk and changing expectations for rates, oil and AI-related investment. Company-linked research discussed JPMorgan’s stablecoin ambitions, housing investment and layoffs, but the supplied evidence does not establish that any of those drove the price action.
JPMorgan fell 3.18%, from $363.11 to $351.55, with the decline concentrated in the final two sessions. The stock slipped to $360.96 on Monday, rebounded to $363.25 on Tuesday, then reversed as volume increased, losing 1.65% Wednesday and 1.60% Thursday. The available evidence points primarily to market and sector pressure rather than a new company-specific shock: Financial Select Sector SPDR Fund units outstanding fell 3.7% week over week, while Treasury yields retreated, a backdrop cited alongside JPMorgan’s decline. The weakness came despite broader market gains in one report. Positive operating news, including stronger trading revenue and a higher 2026 net-interest-income outlook, did not prevent the late-week selloff.
JPM rose $7.15, or 2.03%, from $352.64 to $359.79 over the week. The main catalyst was a stronger-than-expected jobs report, which lifted bank stocks and pushed the Dow Jones bank index to a record, supporting expectations for resilient economic activity. JPM also benefited from renewed attention to CEO Jamie Dimon’s succession outlook after Marianne Lake’s exit, with Stocktwits attributing nearly 3% of the stock’s gain to changing succession dynamics. Shares advanced on each of the first three sessions, reaching $359.24, then gave back $2.94 on Thursday before recovering $1.22 Friday and adding another $2.27 on Monday. Reports that analysts had raised JPM’s fair-value targets provided an additional supportive backdrop.
JPMorgan finished the supplied period at $357.52, up $0.21, or 0.06%, from $357.31. The headline gain masks a sharp reversal: shares fell to $344.71 on July 29, then recovered through July 30 and July 31 before rising to $352.64 on August 3 and $357.52 on August 4. No company-specific announcement in the supplied evidence explains the volatility. The stronger context was a rotation toward financials as an AI-driven technology sell-off unfolded; MarketBeat reported that XLF reached a record high, while Zacks identified JPM among non-technology blue chips supported by earnings growth. JPM also appeared in a report highlighting notable ETF inflows, although no JPM-specific inflow amount was provided.
